Sang-Min Jeon, Ph.D. - Publications

Affiliations: 
2011 University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Cell Biology, Biochemistry, Genetics

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Blaha CS, Ramakrishnan G, Jeon SM, Nogueira V, Rho H, Kang S, Bhaskar P, Terry AR, Aissa AF, Frolov MV, Patra KC, Brooks Robey R, Hay N. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis. Nature Communications. 13: 899. PMID 35173161 DOI: 10.1038/s41467-022-28440-3  0.69
2020 Choi EJ, Jeon SM. NRF2-driven redox metabolism takes center stage in cancer metabolism from an outside-in perspective. Archives of Pharmacal Research. PMID 32130657 DOI: 10.1007/S12272-020-01224-3  0.391
2018 Noh Y, Jeon SM, Shin S. Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy. International Journal of Cancer. PMID 30229901 DOI: 10.1002/Ijc.31870  0.345
2018 DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, Au J, Long CP, Antoniewicz MR, Hay N. Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nature Communications. 9: 2539. PMID 29946147 DOI: 10.1038/S41467-018-04182-Z  0.563
2018 Jeon SM, Hay N. Expanding the concepts of cancer metabolism. Experimental & Molecular Medicine. 50: 32. PMID 29657329 DOI: 10.1038/S12276-018-0070-9  0.558
2018 Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Experimental & Molecular Medicine. 50: 20. PMID 29657326 DOI: 10.1038/S12276-018-0038-9  0.302
2018 Kim SR, Song JH, Ahn JH, Lee GS, Ahn H, Yoon SI, Kang SG, Kim PH, Jeon SM, Choi EJ, Shin S, Cha Y, Cho S, Kim DE, Chang SY, et al. Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation. Antiviral Research. 151: 87-96. PMID 29407486 DOI: 10.1016/J.Antiviral.2018.01.012  0.303
2018 DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, Au J, Long CP, Antoniewicz MR, Hay N. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nature Communications. 9: 446. PMID 29386513 DOI: 10.1038/S41467-017-02733-4  0.653
2017 Jung BJ, Yoo HS, Shin S, Park YJ, Jeon SM. Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities. Biomolecules & Therapeutics. PMID 29212307 DOI: 10.4062/Biomolther.2017.195  0.4
2017 Hong EH, Heo EY, Song JH, Kwon BE, Lee JY, Park Y, Kim J, Chang SY, Chin YW, Jeon SM, Ko HJ. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells. Oncotarget. PMID 28489607 DOI: 10.18632/Oncotarget.17388  0.503
2016 Jeon SM. Regulation and function of AMPK in physiology and diseases. Experimental & Molecular Medicine. 48: e245. PMID 27416781 DOI: 10.1038/Emm.2016.81  0.419
2016 Wang Q, Yu WN, Chen X, Peng XD, Jeon SM, Birnbaum MJ, Guzman G, Hay N. Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. Cancer Cell. PMID 26996309 DOI: 10.1016/J.Ccell.2016.02.008  0.586
2015 Jeon SM, Hay N. The double-edged sword of AMPK signaling in cancer and its therapeutic implications. Archives of Pharmacal Research. 38: 346-57. PMID 25575627 DOI: 10.1007/S12272-015-0549-Z  0.633
2012 Jeon SM, Hay N. The dark face of AMPK as an essential tumor promoter. Cellular Logistics. 2: 197-202. PMID 23676995 DOI: 10.4161/Cl.22651  0.644
2012 Jeon SM, Chandel NS, Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature. 485: 661-5. PMID 22660331 DOI: 10.1038/Nature11066  0.65
2012 Xu PZ, Chen ML, Jeon SM, Peng XD, Hay N. The effect Akt2 deletion on tumor development in Pten(+/-) mice. Oncogene. 31: 518-26. PMID 21743498 DOI: 10.1038/onc.2011.243  0.631
2010 Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, Tonic I, Park Y, Hay N. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Developmental Cell. 18: 592-604. PMID 20412774 DOI: 10.1016/J.Devcel.2010.03.008  0.696
2009 Bhaskar PT, Nogueira V, Patra KC, Jeon SM, Park Y, Robey RB, Hay N. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Molecular and Cellular Biology. 29: 5136-47. PMID 19620286 DOI: 10.1128/Mcb.01946-08  0.686
2009 Chen WS, Peng XD, Wang Y, Xu PZ, Chen ML, Luo Y, Jeon SM, Coleman K, Haschek WM, Bass J, Philipson LH, Hay N. Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. Molecular and Cellular Biology. 29: 3151-62. PMID 19289493 DOI: 10.1128/Mcb.01792-08  0.572
2006 Jeon SM, Choi B, Hong KU, Kim E, Seong YS, Bae CD, Park J. A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts. Biochemical and Biophysical Research Communications. 348: 222-8. PMID 16876122 DOI: 10.1016/J.Bbrc.2006.07.046  0.4
Show low-probability matches.